Table 2. The SARS-CoV-2 specific IFN-γ levels among participants by age group and sex.
*ns=nonsignificant, p-value>0·05 considered as significant, SFU=spot-forming units, IQR=interquartile range
SFU/million cells (median with IQR) | P-value* | ||||
14-18y vs 19-60y | 19-60y vs >60y | 14-18y vs >60y | Gender | ||
Age | ns | ns | ns | - | |
14-18y (n=4) | 209 (22.5 - 360.5) | ||||
19-60y (n=98) | 77 (4 - 371.5) | ||||
>60y (n=23) | 88 (0 - 220) | ||||
Sex | - | - | - | ns | |
Male (n=65) | 118 (18 - 383) | ||||
Female (n=60) | 48 (0 - 289) | ||||
Total participants | n=125 |